Nerivio REN | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

5,153 results for “Nerivio REN”

Trials

View all 4174 →

Active, not recruiting

Nerivio Efficacy Under High-Frequency Use

2,000 participants · First posted Jan 13, 2026

Treatment Patterns Among US Veterans Using Remote Electrical Neuromodulation (REN) for Migraine Treatment

466 participants · First posted Jan 13, 2026

Migraine Prevention With the Remote Electrical Neuromodulation (REN) Wearable: A Real-world Evidence Study

332 participants · First posted Mar 23, 2026

Drugs

View all 554 →

REN-1654

REN-1053

ReN-003

Organizations

View all 110 →

BEIJING TONG REN TANG AUSTRALIA PTY LTD

Australia

Invivyd

United States

Kura Oncology

United States

News

View all 315 →

FDA Expands Nerivio REN Wearable Approval for Migraine Treatment in Children Aged 8+

Theranica's Nerivio REN Wearable Shows Sustained Migraine Efficacy Over Three Years in Real-World Studies

Theranica Presents Real-World Evidence Supporting Drug-Free Migraine Treatment at CNS 2025

Page 1 of 516